Matinas BioPharma Holdings, Inc.
MTNB- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582554
No open-market purchases or sales by Matinas BioPharma Holdings, Inc. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $199.2K in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Matinas BioPharma Holdings, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +3 vs. Q4 2024
- Shares held
- 320.2K
- −49.4K (−13.4%) vs. Q4 2024
- Total value
- $166.5K
- −$27.6K (−14.2%) vs. Q4 2024
- New holders
- 5
- 7 more added
- Sold out
- 2
- 3 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MTNB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $199.2K |
| Q1 2026 | 28 | $177.3K |
| Q4 2025 | 30 | $260.3K |
| Q3 2025 | 28 | $617.7K |
| Q2 2025 | 24 | $254.1K |
| Q1 2025 | 25 | $166.5K |
| Q4 2024 | 22 | $194.1K |
| Q3 2024 | 18 | $1.97M |
| Q2 2024 | 48 | $6.15M |
| Q1 2024 | 42 | $6.91M |
| Q4 2023 | 52 | $5.61M |
| Q3 2023 | 47 | $3.37M |
| Q2 2023 | 51 | $9.31M |
| Q1 2023 | 51 | $12.6M |
| Q4 2022 | 57 | $13.6M |
| Q3 2022 | 55 | $18.0M |
| Q2 2022 | 50 | $21.5M |
| Q1 2022 | 56 | $20.3M |
| Q4 2021 | 66 | $27.4M |
| Q3 2021 | 67 | $33.5M |
| Q2 2021 | 67 | $29.2M |
| Q1 2021 | 80 | $41.7M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Matinas BioPharma Holdings, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| GWM Advisors LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1 | $1 | 0.00% | +1 | New |
| Farther Finance Advisors, LLC | 5 | $3 | 0.00% | +5 | New |
| Rothschild Investment LLC | 14 | $7 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 13 | $7 | 0.00% | +2+18.2% | Added |
| Vision Financial Markets LLC | 40 | $21 | 0.00% | +40 | New |
| EverSource Wealth Advisors, LLC | 60 | $31 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 61 | $32 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 102 | $53 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 144 | $75 | 0.00% | 00.0% | Unchanged |
| Costello Asset Management, INC | 200 | $104 | 0.00% | +200 | New |
| Advisor Group Holdings, Inc. | 210 | $108 | 0.00% | +10+5.0% | Added |
| JPMorgan Chase & Co | 904 | $470 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 976 | $507 | 0.00% | +1+0.1% | Added |
| Tower Research Capital LLC (TRC) | 1,108 | $576 | 0.00% | +6+0.5% | Added |
| UBS Group AG | 1,640 | $853 | 0.00% | −10,673−86.7% | Reduced |
| State Street Corp | 15,322 | $7.97K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 20,974 | $10.9K | 0.00% | +20,974 | New |
| Renaissance Technologies LLC | 22,370 | $11.6K | 0.00% | +4,200+23.1% | Added |
| Susquehanna International Group, LLP | 25,610 | $13.3K | 0.00% | +1,808+7.6% | Added |
| Holos Integrated Wealth LLC | 32,480 | $16.9K | 0.01% | 00.0% | Unchanged |
| Sargent Investment Group, LLC | 41,800 | $21.7K | 0.00% | −22,400−34.9% | Reduced |
| Geode Capital Management, LLC | 46,741 | $24.3K | 0.00% | +3,274+7.5% | Added |
| BlackRock, Inc. | 49,650 | $25.8K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 59,725 | $31.1K | 0.00% | −46,769−43.9% | Reduced |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −35−100.0% | Sold out |